What is the appropriate treatment for heavy continuous vaginal bleeding in a 17‑year‑old female?

Treatment of Heavy Continuous Vaginal Bleeding in a 17-Year-Old Female

First-line treatment consists of NSAIDs (5–7 days) for immediate bleeding control, with hormonal therapy (combined oral contraceptives or estrogen for 10–20 days) as second-line if NSAIDs fail or for more definitive control, after ruling out pregnancy and underlying pathology. 1

Initial Assessment and Stabilization

Before initiating treatment, the following must be evaluated:

• Hemodynamic stability – assess for signs of significant blood loss requiring acute stabilization 2
• Pregnancy status – must be ruled out before any hormonal intervention 3, 1
• Underlying pathology – consider sexually transmitted infections, medication interactions, coagulation disorders (particularly important in adolescents with heavy menstrual bleeding at menarche), thyroid disorders, and structural uterine conditions such as polyps or fibroids 3, 1, 4
• Bleeding history – personal and family bleeding history is essential, as inherited bleeding disorders are more common in adolescents presenting with heavy menstrual bleeding 5, 2

Medical Treatment Algorithm

First-Line: NSAIDs

NSAIDs for 5–7 days during bleeding episodes are the initial treatment of choice for heavy or prolonged bleeding when no underlying pathology is identified. 3, 1, 4

• NSAIDs reduce prostaglandin levels, which are elevated in women with excessive menstrual bleeding 6
• Options include ibuprofen, mefenamic acid, or naproxen 1
• This approach is effective and has fewer side effects than hormonal alternatives 6

Second-Line: Hormonal Therapy

If NSAIDs fail to control bleeding or the patient desires more definitive control, hormonal treatment with low-dose combined oral contraceptives (COCs) or estrogen for 10–20 days should be initiated (if medically eligible). 3, 1, 4

• Combined oral contraceptives stabilize the endometrium and are particularly effective for anovulatory bleeding patterns common in adolescents 4
• Short-course estrogen therapy (10–20 days) is an alternative hormonal option 3, 1
• These agents also provide contraceptive benefit if desired 4

Additional Considerations for Adolescents

Antifibrinolytic agents (such as tranexamic acid for 5 days) may be considered for heavy bleeding, though this is more commonly used in conjunction with other therapies. 1

• Tranexamic acid has been shown to be more effective than NSAIDs at reducing heavy menstrual bleeding 6
• The levonorgestrel-releasing intrauterine system is considered first-line for ongoing heavy menstrual bleeding management and should be considered, especially if contraception is also needed 5

Common Pitfalls and Caveats

Do not assume dysfunctional uterine bleeding without excluding organic causes, particularly in adolescents where coagulation disorders (von Willebrand disease, platelet dysfunction) may present as heavy menstrual bleeding at menarche. 5, 7

Avoid extended or continuous combined hormonal contraceptive regimens as initial therapy – if using CHCs in an extended/continuous manner and breakthrough bleeding occurs, a hormone-free interval of 3–4 consecutive days can help, but this should not be done during the first 21 days of use or more than once per month as it may reduce contraceptive effectiveness. 1, 3

Imaging is not typically first-line in adolescents unless structural pathology is suspected based on history or physical examination. 8

Follow-Up and Escalation

If bleeding persists despite appropriate medical therapy or the patient finds it unacceptable, counsel on alternative methods and consider referral for further evaluation including possible hysteroscopy or additional imaging. 3, 1, 4

• Transvaginal ultrasound with Doppler is the most appropriate imaging study if structural pathology is suspected 8
• Saline-infusion sonohysterography has 96–100% sensitivity for detecting intracavitary lesions if ultrasound is inconclusive 4
• Endometrial sampling is generally not indicated in adolescents unless risk factors for hyperplasia are present (obesity, chronic anovulation, unopposed estrogen exposure) 4

Reassurance and patient education are critical – adolescents should be counseled that irregular bleeding patterns are common and often resolve with treatment, but they should return if bleeding becomes unacceptable or if new symptoms develop. 3, 5